Cargando…

DNA Repair-Based Gene Expression Signature and Distinct Molecular Subtypes for Prediction of Clinical Outcomes in Lung Adenocarcinoma

Objective: To conduct a robust prognostic gene expression signature and characterize molecular subtypes with distinct clinical characteristics for lung adenocarcinoma (LUAD). Methods: Based on DNA repair genes from the GSEA database, a prognostic signature was conducted in the TCGA-LUAD training set...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Bin, Liu, Di, Liu, Yinqiang, Li, Zhixi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729081/ https://www.ncbi.nlm.nih.gov/pubmed/33330576 http://dx.doi.org/10.3389/fmed.2020.615981

Ejemplares similares

Identification of the Signature Genes and Network of Reactive Oxygen Species Related Genes and DNA Repair Genes in Lung Adenocarcinoma
por: Zhao, Ye, et al.
Publicado: (2022)

DNA methylation molecular subtypes for prognosis prediction in lung adenocarcinoma
por: Xu, Duoduo, et al.
Publicado: (2022)

Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma
por: Duan, Jin, et al.
Publicado: (2021)

Identification of Distinct Molecular Subtypes of Endometrioid Adenocarcinoma
por: Lei, Jia, et al.
Publicado: (2021)

Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients
por: Shi, Shanping, et al.
Publicado: (2020)

DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer
por: Shang, Zhen, et al.
Publicado: (2023)

Identification of DNA repair gene signature and potential molecular subtypes in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2023)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma
por: Li, Zhouhua, et al.
Publicado: (2022)

The limits of molecular signatures for pancreatic ductal adenocarcinoma subtyping
por: Lautizi, Manuela, et al.
Publicado: (2022)

Mining Database to Identify Aging-Related Molecular Subtype and Prognostic Signature in Lung Adenocarcinoma
por: Feng, Caihou, et al.
Publicado: (2022)

Distinct molecular subtypes of systemic sclerosis and gene signature with diagnostic capability
por: Wang, Qi, et al.
Publicado: (2023)

Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma
por: Li, Baihui, et al.
Publicado: (2021)

A Five-Gene Signature Associated With DNA Damage Repair Molecular Subtype Predict Overall Survival for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2022)

Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps
por: Zuo, Yanhua, et al.
Publicado: (2023)

An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma
por: Liu, Cong, et al.
Publicado: (2022)

Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy
por: Wang, Qinghua, et al.
Publicado: (2020)

Integrative analysis reveals distinct subtypes with therapeutic implications in KRAS-mutant lung adenocarcinoma
por: Liu, Ke, et al.
Publicado: (2018)

Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability
por: Hong, Shubin, et al.
Publicado: (2022)

Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns
por: Guo, Xiangqian, et al.
Publicado: (2018)

Early-stage serrated adenocarcinomas are divided into several molecularly distinct subtypes
por: Hirano, Daiki, et al.
Publicado: (2019)

Systematic Analysis and Identification of Molecular Subtypes of TRP-Related Genes and Prognosis Prediction in Lung Adenocarcinoma
por: Guo, Yang, et al.
Publicado: (2022)

Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients
por: Yang, Changshun, et al.
Publicado: (2019)

Identification of molecular subtypes in lung adenocarcinoma based on DNA methylation and gene expression profiling—a bioinformatic analysis
por: Wang, Shuying, et al.
Publicado: (2022)

Identification of Signature Genes and Characterizations of Tumor Immune Microenvironment and Tumor Purity in Lung Adenocarcinoma Based on Machine Learning
por: Feng, Haiming, et al.
Publicado: (2022)

The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma
por: Zhang, Yang, et al.
Publicado: (2014)

Mast cell‐based molecular subtypes and signature associated with clinical outcome in early‐stage lung adenocarcinoma
por: Bao, Xuanwen, et al.
Publicado: (2020)

Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma
por: Li, Lifeng, et al.
Publicado: (2023)

A Prognostic Signature of Glycolysis-Related Long Noncoding RNAs for Molecular Subtypes in the Tumor Immune Microenvironment of Lung Adenocarcinoma
por: Li, Na, et al.
Publicado: (2021)

Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma
por: Qiu, Chenjie, et al.
Publicado: (2021)

Identification of an Immune Classification and Prognostic Genes for Lung Adenocarcinoma Based on Immune Cell Signatures
por: Deng, Lili, et al.
Publicado: (2022)

Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Yanfang, et al.
Publicado: (2019)

Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy
por: Xu, Feng, et al.
Publicado: (2020)

A predictive molecular signature consisting of lncRNAs associated with cellular senescence for the prognosis of lung adenocarcinoma
por: Liu, Anbang, et al.
Publicado: (2023)

Prediction of Two Molecular Subtypes of Gastric Cancer Based on Immune Signature
por: Wu, Dan, et al.
Publicado: (2022)

A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma
por: Yang, Xiongtao, et al.
Publicado: (2020)

Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

Characterization of Necroptosis-Related Molecular Subtypes and Therapeutic Response in Lung Adenocarcinoma
por: Zhang, Jingchen, et al.
Publicado: (2022)

DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome
por: Schenkel, L. C., et al.
Publicado: (2021)

Epithelial–Mesenchymal Transition-Based Gene Signature and Distinct Molecular Subtypes for Predicting Clinical Outcomes in Breast Cancer
por: Hou, Lili, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aljqicls7hkp5dl4u73p4si51b